Cite

HARVARD Citation

    Anderson, P. et al. (2016). A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma. Pediatric blood & cancer. 63 (10), pp. 1761-1770. [Online]. 
  
Back to record